http://www.zibb.com/all/theme/cq/Medarex+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Thu, 29 Oct 2009 00:31:55 GMTThu, 29 Oct 2009 00:31:55 GMT608831http://www.zibb.com/all/theme/cq/Medarex+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5626713/Medarex+s+Offer+to+Repurchase+its+Convertible+Senior+Notes+due+May+ExpiresMedarex, Inc., a subsidiary of Bristol-Myers Squibb Company has announced that its offer to repurchase its 2.25 percent Convertible Senior Notes due May 15, 2011 expired on October 23, pursuant to terms of the notice of change in control to holders of the Convertible Notes dated September 23. Thehttp://www.zibb.com/article/5626713/Medarex+s+Offer+to+Repurchase+its+Convertible+Senior+Notes+due+May+ExpiresMedarex IncorporatedThu, 29 Oct 2009 00:31:55 GMThttp://finance.yahoo.com/news/Medarex-Inc-Announces-bw-943602113.html?x=0&.v=1NEW YORK--(BUSINESS WIRE)--Medarex, Inc., a wholly owned subsidiary of Bristol-Myers Squibb Company (NYSE: BMY - News), announced today thathttp://finance.yahoo.com/news/Medarex-Inc-Announces-bw-943602113.html?x=0&.v=1Medarex IncorporatedMon, 26 Oct 2009 13:00:00 GMThttp://www.pharmaceutical-business-review.com/news/hgs_presents_results_for_lupus_trial_090904Human Genome Sciences (HGS) has reported the publication of the results of primary endpoint of two pivotal phase 3 clinical trials of Benlysta (belimumab) in serologically active patients with SLE. The article was pubished by the journal Arthritis Care & Research.http://www.pharmaceutical-business-review.com/news/hgs_presents_results_for_lupus_trial_090904Medarex IncorporatedFri, 04 Sep 2009 00:00:00 GMThttp://www.drugstorenews.com/story.aspx?id=114707A global biopharmaceutical company has completed its tender offer of all outstanding common stock of another company.http://www.drugstorenews.com/story.aspx?id=114707Medarex IncorporatedTue, 01 Sep 2009 10:30:00 GMThttp://www.manufacturing.net/News-Bristol-Myers-Completes-Initial-Offer-For-Medarex-082709.aspxCompany said Thursday it completed its initial tender offer for shares of Medarex Inc., a rival it agreed to buy for $2.1 billion.http://www.manufacturing.net/News-Bristol-Myers-Completes-Initial-Offer-For-Medarex-082709.aspxMedarex IncorporatedThu, 27 Aug 2009 14:52:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7698News and press releases from the pharmaceutical industry. Comprehensive news coverage for the pharmaceutical sector from PharmiWeb.comhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=7698Medarex IncorporatedThu, 27 Aug 2009 01:00:00 GMThttp://www.biospace.com/news_story.aspx?StoryID=153780&full=1All other terms and conditions of the tender offer remain unchanged. As previously disclosed, the condition to the tender offer relating to the expiration of the Hart-Scott-Rodino review period has been satisfied.http://www.biospace.com/news_story.aspx?StoryID=153780&full=1Medarex IncorporatedFri, 21 Aug 2009 12:00:00 GMThttp://www.foxbusiness.com/story/markets/industries/health-care/bristol-myers-extends-medarex-tender-deadline/Bristol-Myers Extends Medarex Tender Deadlinehttp://www.foxbusiness.com/story/markets/industries/health-care/bristol-myers-extends-medarex-tender-deadline/Medarex IncorporatedThu, 20 Aug 2009 21:04:00 GMThttp://www.marketwatch.com/story/bristol-myers-extends-medarex-tender-deadline-2009-08-20?siteid=rssSAN FRANCISCO (MarketWatch) -- Bristol-Myers Squibb Co. said late Thursday it extended its tender offer deadline for shares of Medarex Inc. . The new deadline is Aug. 26 until midnight, compared with the previous Aug. 24 deadline. In July, Bristol-Myers offered $16 a share for outstanding shares ofhttp://www.marketwatch.com/story/bristol-myers-extends-medarex-tender-deadline-2009-08-20?siteid=rssMedarex IncorporatedThu, 20 Aug 2009 21:04:51 GMThttp://www.genengnews.com/news/bnitem.aspx?name=59332676Lonza is offering a fixed-price manufacturing service for generating preclinical quantities (up to 1,000 mg) of microbially derived biopharmaceuticals. The company claims its XSpedhttp://www.genengnews.com/news/bnitem.aspx?name=59332676Medarex IncorporatedFri, 31 Jul 2009 00:00:00 GMThttp://pharmtech.findpharma.com/pharmtech/Manufacturing/BMS-To-Acquire-Medarex/ArticleStandard/Article/detail/614816?ref=25In a move to strengthen development of its biologics portfolio, Bristol-Myers Squibb (BMS, New York) has agreed to acquire the biopharmaceutical company Medarex (Princeton, NJ) for $16 per share or approximately $2.4 billion.http://pharmtech.findpharma.com/pharmtech/Manufacturing/BMS-To-Acquire-Medarex/ArticleStandard/Article/detail/614816?ref=25Medarex IncorporatedThu, 30 Jul 2009 04:00:00 GMThttp://online.wsj.com/article/SB124882584282188545.html?ru=yahoo#mod=yahoo_hsThrough a quirk in insider-trading law, the chairman and chief executive of Medarex had a chance to pocket $250,000, but he didn't take the money.http://online.wsj.com/article/SB124882584282188545.html?ru=yahoo#mod=yahoo_hsMedarex IncorporatedWed, 29 Jul 2009 00:08:57 GMThttp://www.prlog.org/10293132-medarex-inc-faces-investor-lawsuit-alleging-unfair-takeover.htmlMedarex inc. faces Investor Lawsuit alleging unfair takeover. Class Aciton Lawsuit on behalf of certain current investors in Medarex inc. (Public, NASDAQ:MEDX) over possible breach of fiduciary duty by Medarex’s board of directors – Contact the Shareholders Foundation:http://www.prlog.org/10293132-medarex-inc-faces-investor-lawsuit-alleging-unfair-takeover.htmlMedarex IncorporatedMon, 27 Jul 2009 16:46:52 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3056784&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3056784&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2103316837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3056784&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3056784&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2103316837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedarex IncorporatedMon, 27 Jul 2009 07:40:46 GMThttp://seekingalpha.com/article/151078-bristol-myers-gets-its-antibody-deal-at-last?source=feedEP Vantage submits:On the same day that Eli Lilly (LLY) was talking up the commercial prospects of pipeline candidates acquired through its $6.5bnhttp://seekingalpha.com/article/151078-bristol-myers-gets-its-antibody-deal-at-last?source=feedMedarex IncorporatedFri, 24 Jul 2009 08:44:17 GMThttp://blogs.wsj.com/deals/2009/07/23/why-bristol-myers-is-paying-the-biggest-pharma-premium-of-2009/#mod=yahoo_hsIn the world of biotech M&A, it's not about the science. It's about the gamble. Consider the case of Medarex Inc., a maker of a promising a cancer drug, which agreed to by acquired by Bristol Myers Squibb Co. for $2.4 billionhttp://blogs.wsj.com/deals/2009/07/23/why-bristol-myers-is-paying-the-biggest-pharma-premium-of-2009/#mod=yahoo_hsMedarex IncorporatedThu, 23 Jul 2009 21:18:17 GMThttp://www.businessweek.com/bwdaily/dnflash/content/jul2009/db20090723_905955.htm?campaign_id=yhooThe pharmaceutical giant paid top dollar for Medarex, which developed mice with human-like immune systems that may be key to drug R&D.http://www.businessweek.com/bwdaily/dnflash/content/jul2009/db20090723_905955.htm?campaign_id=yhooMedarex IncorporatedThu, 23 Jul 2009 19:45:35 GMThttp://www.newratings.com/en/main/company_headline.m?id=1942513NEW YORK, July 23 (newratings.com) - Analysts at Brean Murray downgrade Medarex (ticker: MEDX) from "buy" to "hold." [more]http://www.newratings.com/en/main/company_headline.m?id=1942513Medarex IncorporatedThu, 23 Jul 2009 19:35:53 GMThttp://www.reuters.com/article/innovationNews/idUSTRE56M5XY20090723NEW YORK (Reuters) - Investors bid up shares of Regeneron Pharmaceuticals Inc and Seattle Genetics Inc on Thursday after Medarex Inc agreed to be acquired byhttp://www.reuters.com/article/innovationNews/idUSTRE56M5XY20090723Medarex IncorporatedThu, 23 Jul 2009 19:14:46 GMThttp://news.yahoo.com/s/nm/20090723/bs_nm/us_biotechInvestors bid up shares of Regeneron Pharmaceuticals Inc and Seattle Genetics Inc on Thursday after Medarex Inc agreed to be acquired by Bristol-Myers Squibb Co at a 90 percent premium.http://news.yahoo.com/s/nm/20090723/bs_nm/us_biotechMedarex IncorporatedThu, 23 Jul 2009 19:07:34 GMThttp://online.barrons.com/article/SB124830632958073985.html?ru=yahoo#mod=yahoobarronsIn less than 24 hours, the drug maker makes a savvy acquisition and announces impressive earnings.http://online.barrons.com/article/SB124830632958073985.html?ru=yahoo#mod=yahoobarronsMedarex IncorporatedThu, 23 Jul 2009 17:04:06 GMThttp://www.smartmoney.com/Investing/Stocks/Stock-Picks-MEDX-Up-SNDK-Down/?afl=yahooBristol-Myers Squibb (BMY) agreed to buy the company for $16 a share in cash — a premium of more than 90% of Medarex's closing price of $8.40 Wednesday. The deal, which is valued at $2.1 billion, has been agreed to by both parties.http://www.smartmoney.com/Investing/Stocks/Stock-Picks-MEDX-Up-SNDK-Down/?afl=yahooMedarex IncorporatedThu, 23 Jul 2009 16:00:00 GMThttp://www.minyanville.com/articles/BMY-medx/index/a/23700/from/yahooMedarex (MEDX) is being acquired by Bristol-Myers (BMY). For stockholders, it’s nearly a double from yesterday’s close. For convertible investors, it’s a nice kiss on a trade that had very little risk. How so? Medarex has a convertible that was due to mature in May 2011.http://www.minyanville.com/articles/BMY-medx/index/a/23700/from/yahooMedarex IncorporatedThu, 23 Jul 2009 15:30:00 GMThttp://www.contractpharma.com/news/2009/07/23/bms_to_acquire_medarexBristol-Myers Squibb has signed an agreement to acquire Medarex, Inc. for $2.1 billion in cash (net of Medarex’s $300 million in cash holdings).http://www.contractpharma.com/news/2009/07/23/bms_to_acquire_medarexMedarex IncorporatedThu, 23 Jul 2009 15:00:00 GMThttp://pubs.acs.org/cen/news/87/i30/8730notw6.htmlA member supported weekly magazine of the American Chemical Society, Chemical And Engineering News covers all the news of the chemical world including science and technology, government and policy, and businesshttp://pubs.acs.org/cen/news/87/i30/8730notw6.htmlMedarex IncorporatedThu, 23 Jul 2009 14:20:00 GMT